Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Fractyl Health Inc (NASDAQ: GUTS) was $1.57 for the day, up 6.80% from the previous closing price of $1.47. In other words, the price has increased by $6.80 from its previous closing price. On the day, 4.3 million shares were traded. GUTS stock price reached its highest trading level at $1.585 during the session, while it also had its lowest trading level at $1.37.
Ratios:
Our analysis of GUTS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 15, 2025, initiated with a Buy rating and assigned the stock a target price of $9. On August 28, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $3.60.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 207544240 and an Enterprise Value of 118380752. For the stock, the TTM Price-to-Sale (P/S) ratio is 10376.95. Its current Enterprise Value per Revenue stands at 6963.574 whereas that against EBITDA is -1.198.
Stock Price History:
The Beta on a monthly basis for GUTS is 2.28, which has changed by -0.3144105 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $3.48, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is 31.43%, while the 200-Day Moving Average is calculated to be 2.75%.
Shares Statistics:
GUTS traded an average of 2.44M shares per day over the past three months and 11486320 shares per day over the past ten days. A total of 132.19M shares are outstanding, with a floating share count of 67.60M. Insiders hold about 48.86% of the company’s shares, while institutions hold 9.61% stake in the company. Shares short for GUTS as of 1757894400 were 1692350 with a Short Ratio of 0.69, compared to 1755216000 on 2404452. Therefore, it implies a Short% of Shares Outstanding of 1692350 and a Short% of Float of 3.2800000000000002.
Earnings Estimates
A comprehensive evaluation of Fractyl Health Inc (GUTS) is underway, with the input of 5.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.14 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.3 and -$1.76 for the fiscal current year, implying an average EPS of -$1.53. EPS for the following year is -$1.08, with 5.0 analysts recommending between -$0.84 and -$1.35.
